Long-Term Monitoring and Kidney Transplantation

Managing Fibronectin glomerulopathy (FNG) is a marathon, not a sprint. Because the disease is usually slowly progressive—though highly variable—long-term care focuses on a risk-based schedule of careful monitoring to preserve your kidney function for as long as possible ^[1]. This page outlines how your care team will track your health and what the journey looks like if you eventually require a kidney transplant.

Long-Term Monitoring Strategy

Since FNG typically changes over 15 to 20 years, your nephrologist will establish a personalized routine to watch for shifts in your kidney health ^[2][3]. While there is no universal “FNG schedule,” standard kidney care involves checking several key markers on a risk-based frequency, which could be several times a year if protein levels are high or you recently changed medications ^[4][5].

Key Markers to Track

• eGFR (Estimated Glomerular Filtration Rate): This is the best overall measure of how well your kidneys are filtering waste. A steady or slow-moving eGFR is the goal ^[6].
• Urine Protein-to-Creatinine Ratio (UPCR): This spot urine test measures how much protein your kidneys are leaking, typically reported in g/g or mg/mg (distinct from a 24-hour urine collection reported in g/day). A significant increase in this number—especially reaching nephrotic-range (approximately >3.5 g/g)—is a known predictor that kidney function may decline more quickly ^[7][8].
• Serum Potassium and Bicarbonate: Medications used to protect your kidneys, like ACE inhibitors or ARBs, can sometimes cause your potassium to rise. Your team will monitor these levels to ensure your medications remain safe for you ^[9][10].
• Blood Pressure: Consistent control is essential. Your doctor will set an individualized home blood pressure target. Guidelines discussing targets below 120/80 mmHg refer to standardized office measurements, which may not be appropriate for home readings due to risks of dizziness ^[11].

Understanding Your Prognosis

It is important to remember that FNG is highly variable. While it is a serious condition, many people maintain stable kidney function for decades.

In a small retrospective series of 19 patients followed for a median of 87 months, roughly 37% (7 out of 19) eventually reached end-stage kidney disease (ESKD) ^[7]. The patients most at risk for this progression were those who already had nephrotic-range protein levels in their urine or signs of permanent scarring called focal segmental glomerulosclerosis (FSGS) on their initial biopsy ^[7].

While keeping your protein levels low and your blood pressure controlled may be associated with better outcomes, the evidence is limited, and these factors do not guarantee a lack of progression ^[12][13]. The 7-of-19 statistic is from a small, potentially referral-biased series and cannot provide an individualized risk percentage.

Kidney Transplantation and Recurrence

If your kidneys eventually reach a point where they can no longer support your body, a kidney transplant is a very effective option. FNG does not prevent you from being a transplant candidate, and many patients have successful outcomes ^[14].

The Risk of Recurrence

One unique aspect of FNG is the possibility of the disease “recurring,” or returning, in the new transplanted kidney (allograft) ^[3][15].

• Timing: Reports of the disease returning in a transplant vary widely in sparse case reports. It has been documented as early as 27 months after surgery in some cases, and as late as 12 years in others ^[3][16].
• What Recurrence Looks Like: The first sign of recurrence is often a slow increase in protein in the urine. A biopsy of the new kidney is usually required to confirm if the fibronectin deposits have returned ^[3][15].
• Success Rates: If the disease returns, outcomes vary. Some recurrent cases progress slowly, while others require careful medical adjustment. Many transplant recipients continue to have functioning grafts for many years despite recurrence, but lifelong anti-rejection immunosuppression is required ^[14][17].

Your transplant team will use regular blood and urine tests to monitor your new kidney and can adjust your treatment plan if any signs of the disease reappear ^[18]. Importantly, if a related living donor is considered, they must undergo genetic counseling and screening to ensure they do not carry an asymptomatic pathogenic variant before donation.